Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 25/02/2019

 Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2019 ,inter alia, to consider and approve In continuation to the earlier matters approved by the Board in its meeting held on 16th January, 2019, the meeting of the Board of Directors of the Company is scheduled to be held on Monday, February 25, 2019 inter-alia to consider the following agendas: 1. Acquire the Equity Shares of M/s Azillian Healthcare Private Limited, subject to the approval of members; 2. Acquire assets from M/s Oxford Pharma (related party), subject to approval of members; 3. To increase the quantum of transactions with related parties, subject to approval of members; 4. Any other matter with the permission of the Chair.
22-02-2019
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Acquisition

 This is to inform the Exchange that the Company has incorporated two Subsidiary Companies under the name and style of Ritz Formulations Private Limited and Sungrace Pharma Private Limited. Disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015 are provided.
25-01-2019
Bigul

Medico Intercontinental Ltd - 539938 - Shareholding for the Period Ended December 31, 2018

 Medico Intercontinental Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here
19-01-2019
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 We hereby wish inform you that the Unaudited financial results for the quarter and nine months ended 31st December, 2018 were approved at the meeting of Board of Directors held on 16th January, 2019. In continuation to the same, the newspaper clipping duly published in English Newspaper (All Edition) and Marathi Newspaper (Mumbai Edition) dated 18th January, 2019 is enclosed herewith.
18-01-2019
Bigul

Medico Intercontinental Ltd - 539938 - Announcement Under Regulation 30 (LODR) - Updates

 Disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015, for the matters considered and approved in the Board Meeting held on 16th January, 2019 have been attached.
16-01-2019
Bigul

Medico Intercontinental Ltd - 539938 - Results- Financial Results For Dec 31, 2018

 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Unaudited Financial Result together with Limited Review Report as issued by the Statutory Auditor of the Company for the Quarter and nine months ended 31st December, 2018 duly approved by the Board of Directors of the Company, at their meeting held on 16th January, 2018
16-01-2019
Bigul

Medico Intercontinental Ltd - 539938 - Outcome of Board Meeting

 Meeting of the Board of Directors of the Company was held today i.e. Wednesday, 16th January, 2019 at 2.00 p.m. at the Corporate Office of the Company situated at 501, 5th Floor, Aditraj Arcade, Near Hetvi Tower, 100 ft. Ring Road, Satellite, Ahmedabad - 380015, wherein the following business matters were considered and approved: 1. Updation of new website of the Company (www.medicointercontinental.com) with all the statutory authorities. 2. Unaudited Financial Results for quarter and nine months ended 31st December, 2018 along with Limited Review Report of the said quarter, from the Statutory Auditor of the Company. 3. Diversification into Pharmaceutical Industry and Change in Main Object Clause of the Memorandum of Association (MoA) of the Company, subject to approval of shareholders/members. 4. Increase in Borrowing limits of the Company pursuant to Section 180(1)(c) of Companies Act, 2013 from Rs. 10 Crores to Rs. 20 Crores, subject to approval of members; 5. Creation of Charge on Movable and Immovable Properties of the Company in respect of Borrowings u/s 180 (1) (a) of the Companies Act, 2013, subject to approval of members; 6. Increase the Authorised Share Capital of the Company to Rs. 10 crores, divided into 1 Crore Equity Shares of Rs. 10/- and consequent alteration in Clause V of the MOA, subject to the approval of members; 7. Increase limits for Loans, Guarantees and Investments u/s 186 of the Companies Act, 2013 from Rs. 10 Crores to Rs. 20 Crores, subject to the approval of members; 8. Proposed Appointment of Mr. Ankur Dave (DIN: 01059786)...
16-01-2019
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015, we hereby inform you that meeting of Board of Directors is scheduled to be held on 16th January, 2019 to inter-alia, consider and approve the unaudited financial results for the quarter and nine months ended 31st December, 2018. In continuation to the same, the newspaper clipping duly published in English Newspaper (All Edition) and Marathi Newspaper (Mumbai Edition) dated 9th January, 2019 is attached herewith.
12-01-2019
Bigul

Medico Intercontinental Ltd - 539938 - Statement Of Investor Complaints For The Quarter Ended December 2018

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Samir ShahDesignation :- Director
12-01-2019
Bigul

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

 Pursuant to Companies Code of Conduct for prevention of Insider Trading in Shares of the Company, the Trading window shall remain closed for dealing in the Company's Shares for all the Board Members and designated Employees from 7th January, 2019 to until forty-eight hours from the conclusion of the said Board Meeting.
07-01-2019
Next Page
Close

Let's Open Free Demat Account